Office Address

860 Omni Boulevard
Suite 103
Newport News, VA 23606

Get Directions

FAX

(757) 586-5277

TPMG Clinical Research Division – Newport News

LOCATION INFORMATION

Mission Statement:

Our mission is to provide superior healthcare that is responsible, physician-directed, and dedicated to protecting our patients’ best interests.


About the TPMG Clinical Research Division:

The Clinical Research Division at Tidewater Physicians Multispecialty Group (TPMG) seeks to conduct clinical research following the highest standards of care.

Founded in 2016, the Clinical Research team has over 60 years of combined experience leading, co-investigating, and coordinating clinical research trials for various disease states. The Division has locations in Newport News and Williamsburg.

Contact us for further information on active clinical trials at our Newport News location. You can also email our office at inquiries@tpmgclinicalresearch.com. 

Meet the Team

For Sponsors


Active Trials:

Cardiovascular:

  • Reduction of risk in patients with established heart disease or are high risk for a cardiac event  
  • Reduction in risk of major cardiovascular events in patients with uncontrolled hypertension  
  • Reduction in risk of a cardiovascular event in patients with a High Lp(a) who are high risk for or have had a cardiovascular event  
  • Prevention of major cardiovascular events in patients who have undergone a procedure or are scheduled for a heart procedure  
  • Severe Hypertriglyceridemia  
  • Heart failure or mildly reduced ejection fraction and obesity  

 

Chronic Kidney Disease:

  • Risk Reduction in Cardiovascular Death and Heart Failure Events in patients with Impaired Kidney Function 
  • Heart and Kidney Protection in patients with Chronic Kidney Disease  

 

High Cholesterol: 

 

Weight loss/Diabetes:

  • Weight loss in participants with obesity with or without Type 2 Diabetes  

 

Closed to Enrollment:

  • Weight management in patients with obesity and type 2 diabetes 
  • Reduce the risk of Chronic Kidney Disease progression   
  • Chronic Kidney Disease Treatment with High Blood Pressure
  • Treatment of Rheumatoid Arthritis with Baricitinib  
  • Reduction of Cardiovascular Risk in Patients with High LP(a)
  • Treatment of Plantar Fasciitis
  • LDL-C Management after Acute Coronary Syndrome
  • Treatment of HbA1c in Type 2 Diabetic with Once-weekly Insulin
  • Treatment of Blood Sugar and Body Weight in Type 2 Diabetics
  • Decrease in Body Weight in Patients with Obesity or Overweight
  • Treatment of Blood Sugar and Body Weight in Type 2 Diabetics not currently taking diabetic medication
  • Treatment of HbA1c and Body Weight in Type 2 Diabetics who are taking metformin or other anti-hyperglycemic drugs
  • Treatment of Blood Sugar in Type 2 Diabetics who are taking metformin
  • Treatment of HbA1c in Type 2 Diabetic with Once-weekly Insulin
  • Treatment of HbA1c and Body Weight in Type 2 Diabetics
  • Chronic Kidney Disease Treatment

 

Published Studies:

 

Past studies include: the treatment of anemia with chronic kidney disease, Lp(a) registry, treatment of Biliary Cholangitis with Pruitis and Atopic Dermatitis, Pfizer COVID vaccination, prevention of Chlamydia trachomatis and Neisseria gonorrhea infection, treatment of chronic cough with stress urinary incontinence, treatment of hypothyroidism, and more.


Notice: Per National Institutes of Health (NIH) requirements, TPMG Clinical Research Financial Conflict of Interest (FCOI) policy is available upon request.

TPMG Clinical Research Division – Newport News

Office Address

860 Omni Boulevard
Suite 103
Newport News, VA 23606

Get Directions

FAX

(757) 586-5277

LOCATION INFORMATION

Mission Statement:

Our mission is to provide superior healthcare that is responsible, physician-directed, and dedicated to protecting our patients’ best interests.


About the TPMG Clinical Research Division:

The Clinical Research Division at Tidewater Physicians Multispecialty Group (TPMG) seeks to conduct clinical research following the highest standards of care.

Founded in 2016, the Clinical Research team has over 60 years of combined experience leading, co-investigating, and coordinating clinical research trials for various disease states. The Division has locations in Newport News and Williamsburg.

Contact us for further information on active clinical trials at our Newport News location. You can also email our office at inquiries@tpmgclinicalresearch.com. 

Meet the Team

For Sponsors


Active Trials:

Cardiovascular:

  • Reduction of risk in patients with established heart disease or are high risk for a cardiac event  
  • Reduction in risk of major cardiovascular events in patients with uncontrolled hypertension  
  • Reduction in risk of a cardiovascular event in patients with a High Lp(a) who are high risk for or have had a cardiovascular event  
  • Prevention of major cardiovascular events in patients who have undergone a procedure or are scheduled for a heart procedure  
  • Severe Hypertriglyceridemia  
  • Heart failure or mildly reduced ejection fraction and obesity  

 

Chronic Kidney Disease:

  • Risk Reduction in Cardiovascular Death and Heart Failure Events in patients with Impaired Kidney Function 
  • Heart and Kidney Protection in patients with Chronic Kidney Disease  

 

High Cholesterol: 

 

Weight loss/Diabetes:

  • Weight loss in participants with obesity with or without Type 2 Diabetes  

 

Closed to Enrollment:

  • Weight management in patients with obesity and type 2 diabetes 
  • Reduce the risk of Chronic Kidney Disease progression   
  • Chronic Kidney Disease Treatment with High Blood Pressure
  • Treatment of Rheumatoid Arthritis with Baricitinib  
  • Reduction of Cardiovascular Risk in Patients with High LP(a)
  • Treatment of Plantar Fasciitis
  • LDL-C Management after Acute Coronary Syndrome
  • Treatment of HbA1c in Type 2 Diabetic with Once-weekly Insulin
  • Treatment of Blood Sugar and Body Weight in Type 2 Diabetics
  • Decrease in Body Weight in Patients with Obesity or Overweight
  • Treatment of Blood Sugar and Body Weight in Type 2 Diabetics not currently taking diabetic medication
  • Treatment of HbA1c and Body Weight in Type 2 Diabetics who are taking metformin or other anti-hyperglycemic drugs
  • Treatment of Blood Sugar in Type 2 Diabetics who are taking metformin
  • Treatment of HbA1c in Type 2 Diabetic with Once-weekly Insulin
  • Treatment of HbA1c and Body Weight in Type 2 Diabetics
  • Chronic Kidney Disease Treatment

 

Published Studies:

 

Past studies include: the treatment of anemia with chronic kidney disease, Lp(a) registry, treatment of Biliary Cholangitis with Pruitis and Atopic Dermatitis, Pfizer COVID vaccination, prevention of Chlamydia trachomatis and Neisseria gonorrhea infection, treatment of chronic cough with stress urinary incontinence, treatment of hypothyroidism, and more.


Notice: Per National Institutes of Health (NIH) requirements, TPMG Clinical Research Financial Conflict of Interest (FCOI) policy is available upon request.